Oragenics names John Spencer CFO effective July 1, 2026
Oragenics appointed John Spencer, its Senior Controller, as Chief Financial Officer effective July 1, 2026, under an employment agreement with $200,000 base pay and a $25,000 option award. At the June 29, 2026 annual meeting, shareholders re-elected six directors, approved an advisory vote on executive compensation, and authorized the Board to enact a reverse stock split at a ratio between 1-for-2 and 1-for-50 within one year.
Key points
- John Spencer, age 32, was named CFO effective July 1, 2026, after joining the company in April 2025 as Senior Controller.
- Employment agreement provides base compensation of $200,000; Spencer received an option award equal to $25,000.
- At the June 29, 2026 annual meeting, the reverse stock split authorization received 1,239,961 votes for and 836,159 against.
- Shareholders re-elected six directors and ratified Cherry Bekaert LLP as independent auditors for 2026 (1,887,381 for, 184,883 against).
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.